PMA status proposed in US for pelvic organ prolapse meshes
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is proposing that surgical meshes used for transvaginal repair of pelvic organ prolapse be regulated under tougher standards based on health risks associated with the devices.